Final results of a phase 1 study of loncastuximab tesirine in relapsed/refractory B-cell non-Hodgkin lymphoma von Hamadani, Mehdi, Radford, John, Carlo-Stella, Carmelo, Caimi, Paolo F., Reid, Erin, O'Connor, Owen A., Feingold, Jay M., Ardeshna, Kirit M., Townsend, William, Solh, Melhem, Heffner, Leonard T., Ungar, David, Wang, Luqiang, Boni, Joseph, Havenith, Karin, Qin, Yajuan, Kahl, Brad S.

Volltext

A Phase I Study of ADCT-402 (Loncastuximab Tesirine), a Novel Pyrrolobenzodiazepine-Based Antibody-Drug Conjugate, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma von Kahl, Brad S, Hamadani, Mehdi, Radford, John, Carlo-Stella, Carmelo, Caimi, Paolo, Reid, Erin, Feingold, Jay M, Ardeshna, Kirit M, Solh, Melhem, Heffner, Leonard T, Ungar, David, He, Shui, Boni, Joseph, Havenith, Karin, O'Connor, Owen A

Volltext

Approaches and limitations of phosphatidylinositol-3-kinase pathway activation status as a predictive biomarker in the clinical development of targeted therapy von Coughlin, Christina M, Johnston, Daniel S, Strahs, Andrew, Burczynski, Michael E, Bacus, Sarah, Hill, Jason, Feingold, Jay M, Zacharchuk, Charles, Berkenblit, Anna

Volltext

Camidanlumab tesirine, an antibody-drug conjugate, in relapsed/refractory CD25-positive acute myeloid leukemia or acute lymphoblastic leukemia: A phase I study von Goldberg, Aaron D., Atallah, Ehab, Rizzieri, David, Walter, Roland B., Chung, Ki-Young, Spira, Alexander, Stock, Wendy, Tallman, Martin S., Cruz, Hans G., Boni, Joseph, Havenith, Karin E.G., Chao, Grace, Feingold, Jay M., Wuerthner, Jens, Solh, Melhem

Volltext

Idiopathic pneumonia syndrome following myeloablative chemotherapy and autologous transplantation von Bilgrami, SF, Metersky, ML, McNally, D, Naqvi, BH, Kapur, D, Raible, D, Bona, RD, Edwards, RL, Feingold, JM, Clive, JM, Tutschka, PJ

Volltext

Regional Thrombolysis with Urokinase for Central Venous Catheter-related Thrombosis in Patients Undergoing High-dose Chemotherapy with Autologous Blood Stem Cell Rescue von Schindler, Joanne, Bona, Robert D., Chen, Harry H., Feingold, Jay M., Edwards, Richard L., Tutschka, Peter J., Bilgrami, Syed

Volltext

Incidence of Sinusoidal Obstruction Syndrome Following Mylotarg (Gemtuzumab Ozogamicin, GO): a Prospective Observational Study in Routine Clinical Practice von Tallman, Marti n S, McDonald, George B, DeLeve, Laurie D, Obi-Tabot, Eliot, Kollmer, Carl, Feingold, Jay M

Volltext

Interim Analysis of a Post Marketing All Cases Surveillance Study of Mylotarg in Japan von Usui, Noriko, Takeuchi, Jin, Sakamaki, Hisashi, Ohno, Ryuzo, Suzukawa, Michio, Obi-Tabot, Eliot, Feingold, Jay M.

Volltext

A Post-Marketing Surveillance Study of the Safety and Efficiacy of Refacto® (Moroctocog Alfa, B-Domain Deleted Recombinant Factor VIII) (St. Louis-Derived Active Substance in the T... von Feingold, Jay M., Smith, Mark P., Littlewood, Richard, Giangrande, Paul

Volltext

An autonomously replicating eukaryotic expression vector with a tetracycline-responsive promoter von Lang, Zhihui, Feingold, Jay M.

Volltext

Streamlined Approach to Creating Yeast Artificial Chromosome Libraries from Specialized Cell Sources von Feingold, Jay M., Ogden, Sheila D., Denny, Christopher T.

Volltext

Base Sequence Damage in DNA from X-irradiated Monkey CV-1 Cells von Feingold, Jay M., Masch, Julia, Maio, Joseph, Mendez, Frances, Bases, Robert

Volltext

Combination therapy for the treatment of acute leukemia and myelodysplastic syndrome von SHERMAN MATTHEW L, FEINGOLD JAY M, BERGER MARK S, LEOPOLD LANCE H

Volltext bestellen

Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma (LOTIS-2): a multicentre, open-label, single-arm, phase 2 trial von Caimi, Paolo F, Ai, Weiyun, Alderuccio, Juan Pablo, Ardeshna, Kirit M, Hamadani, Mehdi, Hess, Brian, Kahl, Brad S, Radford, John, Solh, Melhem, Stathis, Anastasios, Zinzani, Pier Luigi, Havenith, Karin, Feingold, Jay, He, Shui, Qin, Yajuan, Ungar, David, Zhang, Xiaoyan, Carlo-Stella, Carmelo

Volltext

Camidanlumab tesirine in patients with relapsed or refractory lymphoma: a phase 1, open-label, multicentre, dose-escalation, dose-expansion study von Hamadani, Mehdi, Collins, Graham P, Caimi, Paolo F, Samaniego, Felipe, Spira, Alexander, Davies, Andrew, Radford, John, Menne, Tobias, Karnad, Anand, Zain, Jasmine M, Fields, Paul, Havenith, Karin, Cruz, Hans G, He, Shui, Boni, Joseph, Feingold, Jay, Wuerthner, Jens, Horwitz, Steven

Volltext

LXR ligand lowers LDL cholesterol in primates, is lipid neutral in hamster, and reduces atherosclerosis in mouse[S] von Quinet, Elaine M., Basso, Michael D., Halpern, Anita R., Yates, David W., Steffan, Robert J., Clerin, Valerie, Resmini, Christine, Keith, James C., Berrodin, Thomas J., Feingold, Irene, Zhong, Wenyan, Hartman, Helen B., Evans, Mark J., Gardell, Stephen J., DiBlasio-Smith, Elizabeth, Mounts, William M., LaVallie, Edward R., Wrobel, Jay, Nambi, Ponnal, Vlasuk, George P.

Volltext

Duration of response to loncastuximab tesirine in relapsed/refractory diffuse large B-cell lymphoma by demographic and clinical characteristics: Subgroup analyses from LOTIS 2 von Caimi, Paolo, Ai, Weiyun Z., Alderuccio, Juan Pablo, Ardeshna, Kirit, Hamadani, Mehdi, Hess, Brian T., Kahl, Brad S., Radford, John A., Solh, Melhem M., Stathis, Anastasios, Zinzani, Pier Luigi, Feingold, Jay Marshall, Ungar, David, Qin, Yajuan, He, Shui, Carlo-Stella, Carmelo

Volltext

Inflammatory Markers at Hospital Discharge Predict Subsequent Mortality after Pneumonia and Sepsis von Yende, Sachin, D'Angelo, Gina, Kellum, John A, Weissfeld, Lisa, Fine, Jonathan, Welch, Robert D, Kong, Lan, Carter, Melinda, Angus, Derek C, GenIMS Investigators

Volltext

Preliminary Results of a Phase 2 Study of Camidanlumab Tesirine (Cami), a Novel Pyrrolobenzodiazepine-Based Antibody-Drug Conjugate, in Patients with Relapsed or Refractory Hodgkin... von Herrera, Alex F., Carlo-Stella, Carmelo, Collins, Graham P., Maddocks, Kami J., Bartlett, Nancy L., Savage, Kerry J., Caimi, Paolo F, Hess, Brian T., Zinzani, Pier Luigi, Cruz, Hans G, Wang, Luqiang, Feingold, Jay, Wuerthner, Jens, Ansell, Stephen M.

Volltext

Efficacy and Safety of Loncastuximab Tesirine (ADCT-402) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma von Caimi, Paolo F, Ai, Weiyun Z., Alderuccio, Juan Pablo, Ardeshna, Kirit M., Hamadani, Mehdi, Hess, Brian T., Kahl, Brad S., Radford, John A., Solh, Melhem, Stathis, Anastasios, Zinzani, Pier Luigi, Feingold, Jay, Ungar, David, Qin, Yajuan, He, Shui, Carlo-Stella, Carmelo

Volltext